Evidence map›Paper›PMID 31453878›Full record

ArticleCornea2019

Glaucoma After Corneal Trauma or Surgery-A Rapid, Inflammatory, IOP-Independent Pathway.

Claes H Dohlman, Chengxin Zhou, Fengyang Lei, Fabiano Cade, Caio V Regatieri, Alja Črnej, Jan G Dohlman, Lucy Q Shen, Eleftherios I Paschalis

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Cornea, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04337944 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Impact of Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis in Reducing Postoperative Complications

TypeinterventionalSponsorCentre hospitalier de l'Université de Montréal (CHUM)Ran2020 to 2025Enrolled20ConditionsCorneal Transplantation, Glaucoma and Ocular Hypertension, Postoperative Complications, VitrectomyArmsBoston keratoprosthesis type 1 and anterior hyaloid membrane peeling assisted by endoscopy
NCT04339907 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Uncovering Inflammatory Mediators of Glaucoma Pathogenesis After Corneal Transplantation in Aqueous Humor and Tears

TypeinterventionalSponsorCentre hospitalier de l'Université de Montréal (CHUM)Ran2020 to 2025Enrolled200ConditionsGlaucoma, Corneal Transplantation, InflammationArmsSampling of tears, Sampling of aqueous humor
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Immune cells in lens injury repair and fibrosis.Experimental eye research · 2021
    Review
  16. Article
  17. Intrinsic Optical Properties of Boston Keratoprosthesis.Translational vision science & technology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Claes H DohlmanCornea Service, Glaucoma Service and Boston Keratoprosthesis Laboratory, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA.
Chengxin Zhou
Fengyang Lei
Fabiano Cade
Caio V Regatieri
Alja Črnej
Jan G Dohlman
Lucy Q Shen
Eleftherios I Paschalis
Creative Commons · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review clinical aspects and cellular and molecular steps in the development of long-term glaucoma after corneal surgery or acute trauma-especially the pivotal role of tumor necrosis factor alpha (TNF-α), the rapidity of the secondary damage to the retinal ganglion cells, and the clinical promise of early antiinflammatory intervention.

methodsA series of laboratory studies on post-injury and post-surgery glaucoma have been compared to clinical outcome studies on the subject, focusing particularly on the vulnerability of the retinal ganglion cells. Alkali burn to the cornea of mice and rabbits served as the main experimental model. TNF-α titer, ganglion cell apoptosis, and depletion of optic nerve axons have been examined. Anti-TNF-α antibodies or corticosteroids have been used to protect the retinal ganglion cells. Intraocular pressure (IOP) postburn was recorded by manometric methods.

resultsIn animals with alkali burn to the cornea, damage to the retina can occur within 24 to 72 hours. This is not because of a direct pH change posteriorly-the alkali is effectively buffered at the iris-lens level. Rather, TNF-α (and other inflammatory cytokines), generated anteriorly, rapidly diffuses posteriorly to cause apoptosis of the ganglion cells. During this time, the IOP remains much lower than the reported values required to cause ganglion cell damage. The TNF-α antibody infliximab or corticosteroids, if administered promptly, are markedly protective of the ganglion cells.

conclusionsA rapidly initiated, inflammatory (TNF-α mediated), IOP-independent pathway to glaucoma, resulting from acute anterior segment trauma or surgery, has been identified in laboratory studies. Prompt prophylactic treatment with antiinflammatory agents has been shown to be markedly neuroprotective of retinal ganglion cells, presumably capable of reducing the risk of late glaucoma.

Indexed as

AnimalsBurns, ChemicalCorneal DiseasesCorneal InjuriesEye BurnsGlaucomaIntraocular PressureMiceRabbitsRefractive Surgical ProceduresRetinal Ganglion CellsTonometry, OcularTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID31453878
PMCPMC6830965
OpenAlexW2970370739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.